There has been a greater awareness of the clinical syndrome of rheumatoid arthritis, leucopenia, and splenomegaly since Felty described his 5 patients in 1924. Although the association of splenomegaly, leucopenia, and increased frequency of infections is well recognized, these features do not always present together in one patient, thus excluding a simple cause and effect explanation. Furthermore, several aspects of the clinical course of Felty's syndrome remain unclear, for example the features of the articular and extra-articular disease, the aetiology of the leucopenia, the role of splenectomy, the duration of leucocytosis, and the frequency of infections after splenectomy. We attempted to answer these questions by reviewing 34 cases with Felty's syndrome observed for a mean of 56 months.
Materials and methods
Thirty-four patients with Felty's syndrome at the Wellesley Hospital were selected for study. They fulfilled all of the following criteria. (1) Classical or definite rheumatoid arthritis (ARA criteria). (2) Splenomegaly as detected by physical examination or by radioisotope scan. (3) Leucopenia of <4 0x109/l, or neutropenia of <2-0x109/l, or thrombocytopenia of <100 x l09/l. (4) known causes for the cytopenia (e.g. drugs) or the splenomegaly (e.g. lymphoma).
All patients were evaluated at the time of diagnosis of Felty's syndrome, and 27 were still being followed. 4 died and 3 have been lost to follow-up. Splenectomy had been performed in 12 of these patients. A detailed clinical and laboratory evaluation according to a predesigned protocol was carried out on 18 of these patients in the first half of 1975. The level of joint inflanunatory activity was estimated according to the articular index method of Lansbury (1972) , and by a count of inflamed joints and of synovial effusions. The severity of destruction in each joint was scored from stage 1+ to 3+ according to the method of Steinbrocker et al. (1949) and all those with 2 + or 3 + were considered to have advanced joint destruction. X-rays of the hands and feet were evaluated according to the method of Kellgren et al. (1963) and those with stage III and IV were tabulated.
Bone marrow aspirations were performed in 30 patients at the time of diagnosis and evaluated by an independent assessor. Serological tests included latex fixation for rheumatoid factor, fluorescent antinuclear antibody test, total haemolytic complement, C3, cellulose acetate electrophoresis, quantitation of immunoglobulins (IgG, IgA, IgM) , and DNA-binding by the Farr technique using 1251. Intradermal skin tests using SKSD (10 U SK and induration measured in mm 48 hours after application. Peripheral blood B and T lymphocyte populations were estimated by immune (Bianco et al., 1970) and nonimmune (Jondal et al., 1972) sheep erythrocyte rosette formation, respectively, in 8 patients. In vitro lymphocyte responses to phytohaemagglutinin, pokeweed mitogen, and concanavalin A were determined by estimating the incorporation of 3H-thymidine into the DNA of blast cells (Greaves et al., 1974) . These mitogen studies were performed before skin testing in 10 patients. Results are expressed as ratios of values compared with those of age-and sex-matched controls.
The coil test as described by Jensen et al. (1973) was used to study neutrophil kinetics in 7 Felty's patients (2 had had splenectomy), in 1 rheumatoid patient without Felty's, and in 2 normal subjects. Blood was withdrawn from each subject and approximately 500 ml blood was run into a Gambro dialyser with a 13-5 ,um membrane (purchased from Gambro Lundia, Mississauga, Ontario). When the coil was filled the blood was allowed to stagnate for 30 minutes and then was infused back into the subject. Blood specimens for total white blood cell count and differentials were drawn from the opposite arm immediately before and after the original sample was taken, immediately before reinfusion of the coil blood and at 5, 15, 30, and 45 minutes, and 1, 2, 3, and 4 hours after the reinfusion was begun. The mean of the three preinfusion blood counts was taken as the baseline value for the neutrophil counts. The peak count was the highest recorded after the reinfusion was begun. (Ruderman et al., 1968; Barnes et al., 1971) and with a large group of patients (127) with definite or classical rheumatoid arthritis severe enough to be admitted for treatment (Gordon et al., 1973) .
At the time of diagnosis of Felty's syndrome, 87 % of the patients had active arthritis (Table 1 ). The mean (± SD) number of active joints, effusions, and articular index were 20-6+12 8 (n = 26), 2 8±3*5 (n = 22), and 92 6±52 1 (n = 21), respectively. Joint destruction was found in 91 %. Evaluation of hand x-rays showed stage 4 changes in 16 patients, stage 3 in 9, stage 2 in 6, stage 1 in 1, and stage 0 in 1 (Table 1) .
Extra-articular manifestations of rheumatoid disease in addition to Felty's syndrome and anaemia were present in all but 2 patients, the mean number per patient being 2-9 (Tables 2, 3). Rheumatoid Barnes et al., (1971 Of the 4 patients who died, only the one with chronic lymphocytic leukaemia had had a splenectomy. One patient died from bronchopneumonia superimposed on lungs markedly affected by fibrosis and amyloidosis, the latter also affecting the liver and gastrointestinal tract. A third patient died of generalized inanition, and the fourth of myocardial infarction.
LABORATORY EVALUATION
The erythrocyte sedimentation rate (ESR, Westergren) (Table 4) at diagnosis was 85±31 (SD) mm/h. 27 of the 34 patients were anaemic, the mean haemoglobin being 11 -1 ±2 0 (SD) g/dl. The mean highest recorded reticulocyte count was 3 *2% (range 0 4-6-1 %.). 12 of 15 patients had low serum iron concentrations (mean 41-3 ±29-7 ,ug/100 ml; 7'4±5 3 ,umol/l) and 2/15 had a raised iron binding capacity (mean 319 ±54 ,tg/100 ml; 57±97 ,umol/l).
All but one patient was leucopenic (lowest mean recorded value 2 14±1 06 (SD) x 109/1), and 29/33 patients were neutropenic including the patient who was not leucopenic. The mean (±SD) lymphocyte, monocyte, and eosinophil counts were 0-9±0t83, 0-11±0-08, 007±0'08 x109/l. All but onepatient was lymphocytopenic (<1 5 x 109/l) and none had eosinophilia. Thrombocytopenia (<100 platelets x 109/l) was present in 5/33 patients, the mean lowest platelet count being 195 ± 108 x 109/1. Bone marrow aspirations performed on 30 of the patients at the time of diagnosis (Table 5) showed hypercellularity in most instances. In 90% of marrows granulopoiesis was accelerated or normal, with a left shift in 60%. A surprising finding was a lack of iron staining in 67% of patients. Patients were thought to be losing blood through the rectum if 3 or more stool specimens gave a 2+ or greater guaiac result. 5 of 13 patients were thus losing blood through the rectum at the time of stool examination. (Table 4) . No significantly abnormal urinary sediment was associated with these changes in most cases. Renal function tests in 22 patients showed a mean serum creatinine of 0-91 mg/100 ml (80 5 ,mol/l) and a creatinine clearance of 82 ml/min. Only 2/29 patients had been taking potentially nephrotoxic drugs within 3 months of the assessments. Renal histology was available for 3. Focal glomerulonephritis and ischaemic changes due to arteriosclerosis was present in one patient with >4-0 g protein/24 hours. Another patient with proteinuria had mild glomerular alterations with hypercellularity and increased mesangial matrix. Inmuunofluorescence was negative but electron microscopy showed fusion of the foot processes of the epithelial cells. The third specimen, taken post mortem from the kidney of the patient with amyloidosis, showed arterial and arteriolar nephrosclerosis but no amyloidosis though there was significant proteinuria.
IMMUNOLOGICAL EVALUATION (TABLE 4)
All patients had rheumatoid factor as determined by the latex fixation test. With no titre being diluted out to > 1/5120, the mean titre was 1/2898 ± 1/1945 (SD). A titre of > 1/640 was present in 29/34 patients. LE cells were detected in 11/27 (41 %) patients and a positive antinuclear factor was present in 16/29 (55 %). DNA-binding was not raised in the 8 patients in whom the test was performed, including 2 patients with antinuclear factor. Hypocomplementaemia was present in 2/22 (9%) patients. The mean total haemolytic complement was 177 ±42 units (normal 130-220) Anergy as determined by the four skin tests was present in 4/16 (25%) patients. In the mitogen studies, the mean (±SD) results for phytohaemagglutinin (PHA), concanavalin A (Con A), and pokeweed mitogen (PWM), expressed as a ratio of patient to control, in 10 patients were 0-9 ±03, 0 8±0 6, and 10±0 5, respectively. Of these 10 patients, 3 were tested after splenectomy. PHA stimulation was considered to be significantly low in 2, both of whom had had splenectomies. 5 patients had low counts when stimulated by Con A including the 3 splenectomized patients. 3 patients had a poor response to PWM including 1 of the splenectomized patients. One patient had increased responses to Con A and PWM and another to PWM alone. Both of these patients still had their spleens.
COMPARISON OF 12 PATIENTS BEFORE AND AFTER SPLENECTOMY (TABLE 6) Twelve patients were evaluated after splenectomy, after a mean of 27 6 months (Table 6 ). Mean haemoglobin values rose only slightly from 11-8-13-0 g/dl. However, the white cell count increased from a mean of 1 5 to 8 4x109/l (P<0.001), the increase being reflected both in the neutrophils (0-4-422x1O9/l; P<0 01) and the lymphocytes (0 8-40x 109/l; P<0 01). The platelet count rose from 130 to 407 x 109/l (P<0 001). All patients had white cell counts >4 2xlO9/1, neutrophil counts >14 x 109/l, and platelets >220 x 109/l after splenectomy. The mean ESR was reduced from 72 to 53 mm/h and the gammaglobulin level reduced from 22 6 to 20 3 g/l after splenectomy.
Seven patients had bone marrow examinations before and after splenectomy, the mean interval after splenectomy being 30 6 months ( Table 7) . Cellularity was increased in all 7 before splenectomy and judged to be normal in 3 after splenectomy. Increased granulopoiesis returned to normal in 6 of the 7 after splenectomy. Erythropoiesis was increased in 6 of 7 before splenectomy and returned to normal in 2 after splenectomy. Before splenectomy, megakaryocytes were increased in 6 patients and decreased in the seventh, but afterwards were normal in 4 of the 6 and in the seventh. Stainable group.bmj.com on October 14, 2017 -Published by http://ard.bmj.com/ Downloaded from iron was absent in 6 of 7 patients before splenectomy and returned to normal in only 1, 29 months after splenectomy.
INFECTION
Twenty-seven patients were diagnosed as having 41 episodes of infection. Of these, 8 underwent splenectomy. In most infection occurred between a few months and 2 years before splenectomy and was indeed the indication for splenectomy. Infections in the 27 patients tended to be due to common organisms (staphylococcus, streptococcus, haemophilus, and Gram-negative bacilli comprising 92% of the infections) and responded to usual antibiotic therapy. In 9 instances of 'clinical sepsis', consisting of fever and rigors, no specific infectious agent was isolated, but recovery occurred with antibiotic therapy. In the 8 patients who underwent splenectomy 17 episodes of infection occurred in 4 during a mean follow-up of 27 6 months. The type and location of infection had a similar distribution to those occurring before splenectomy. The other 4 have remained free of bacterial infection after a mean follow-up of 48 months, although 2 developed herpes zoster. 4 additional patients who had no prior infections underwent splenectomy. 1 died in the immediate postoperative period of Gramnegative sepsis. The other 3 have remained free of bacterial infection for a mean of 63 months.
Prednisone was taken by 22 patients, none receiving more than 15 mg/day. Of 27 patients who had infection before splenectomy, 19 had received steroids compared with 3/7 patients who developed no infections.
LEUCOCYTE KINETICS (TABLE 8) We studied leucocyte kinetics by the coil test, which has been shown to express bone marrow neutrophil reserve (Brubaker and Nolph, 1971) . Although our numbers are small, none of our patients with splenomegaly showed as great a neutrophil reserve as did the two patients with Felty's syndrome without spleens, and 4/5 patients with splenomegaly had lower neutrophil reserves than the 3 control patients.
Discussion
Our experience shows that Felty's syndrome is a form of 'super' rheumatoid disease as reflected by the severity of joint disease, the prominence of extra-articular features, and a remarkable incidence of infections. Assessment of joint disease showed that patients had very destructive arthritis with a much higher incidence of deformities and bone and cartilage destruction than did a group of patients with definite or classical rheumatoid arthritis (Table 1) . When compared to patients with severe rheumatoid disease, the group with Felty's syndrome showed a higher percentage of deformity (91 % vs 66%) and of destruction on x-ray (74% vs 56%). We also found our Felty's patients to have more active (inflammatory) articular disease than the comparison group as reflected by the articular index and the percentage of patients with joint effusions (77 %) ( Table 1 ). This severe articular disease has not been emphasized in the past (Felty, 1924; Ruderman et al., 1968; Barnes et al., 1971; Louie and Pearson, 1971) . Excluding the haematological features of Felty's syndrome, 94% of our patients had extra-articular features, with a mean of 2 9 per patient. This compares with an overall incidence of 76 % in Gordon's group of hospitalized rheumatoid arthritis patients (Gordon et al., 1973) . In comparing the three studies of Felty's syndrome ( Table 3 ) it appears that nodules, splenomegaly, and lymphadenopathy are more frequent in these patients than in the large group of hospitalized rheumatoid patients. The majority of patients with Felty's syndrome were anaemic (79 %) or leucopenic (97 %), but only 15 % were thrombocytopenic. All but one patient in our series showed lymphocytopenia (<1 5 x 109/l). In agreement with previous reports (Felty, 1924; Ruderman et al., 1968; Barnes et al., 1971; Louie and Pearson, 1971; Moore et al., 1971) , bone marrow studies in these patients showed normal or increased cellularity in 74 % and increased granulopoiesis in 90%. In only 3 patients was decreased cellularity observed. Surprisingly, iron stores were absent in 67 % and significantly reduced in a further iron staining (Raymond et al., 1965; Cartwright, 1966; Wardle and Attan, 1967; Douglas and Adamson, 1975) . It is possible that in our series blood loss had occurred previously and stores had not been replenished, or that iron absorption was faulty in these patients.
Liver involvement occurred in at least onequarter of our patients (raised sulphobromophthalein in 27 %). However, pathological studies showed lobular hepatitis in 1, amyloidosis and haemangiomata in 1, and nonspecific findings in 5. Previous studies (Ritland, 1973; Blendis et al., 1974) have reported finding nodular regenerative hepatitis, cirrhosis, or lymphocytic infiltration of the sinusoids and portal triads in Felty's syndrome.
The kidney is often thought to be spared in rheumatoid disease, proteinuria being explained by complications such as urinary tract infections, amyloidosis, or as secondary to drug therapy. 39% of our patients excreted more than 500 mg protein/24 hours in the absence of any other obvious cause for proteinuria. Histology in 3 patients showed focal glomerulonephritis in 2 and nephrosclerosis in 1. Whether this proteinuria is glomerular in origin (Baggenstoss and Rosenberg, 1943; Pollak et al., 1962; Brun et al., 1965) secondary to immune complex deposition, or tubular in origin secondary to an interstitial nephritis (Bulger et al., 1968) occasionally seen in rheumatoid arthritis cannot be answered without more pathological and immunofluorescent data. Light-chain excretion in the urine as described by Gordon et al. (1966) was not detected in 2 of our patients.
Many patients in all three studies of Felty's syndrome had raised immunoglobulin levels and a number of circulating autoantibodies (Table 4) . The incidence of positive LE cells, rheumatoid factor, and antinuclear factor was greater in these patients than in other studies of rheumatoid arthritis (Ziff and Baum, 1972 We failed to show a correlation between severity of leucopenia and spleen size in agreement with Moore et al. (1971) and Ruderman et al. (1968) . A specific antileucocyte antibody, as described by Faber and Elling (1966) and Calabresi et al. (1959) , might be implicated in the leucopenia of some Felty's patients. Our kinetic studies suggest that Felty's patients with spleens have decreased neutrophil reserves. Bone marrow examinations in these patients show an exhaustion of the normal intramarrow reserves of mature neutrophils (a shift to the left). The 2 patients in whom we studied leucocyte kinetics after splenectomy showed normal neutrophil reserves.
Splenectomy in our patients resulted in a sustained rise of white blood cell count, return of bone marrow to normal granulopoietic morphology, improvement of anaemia, and sustained rise of platelet counts. Splenectomy did not, however, result in increased bone marrow iron stores nor did it significantly affect the incidence of infections. In fact, we cannot exclude the possibility that splenectomy might have been instrumental in the fatal infection in one of our patients. 
